Feds: Theranos lab inspection finds ‘immediate jeopardy’ to patients / Arizona Republic
Federal inspectors say that a California lab owned by Theranos, a Silicon Valley company that also conducts widespread blood testing in metro Phoenix, had deficient practices, including one that posed “immediate jeopardy to patient health and safety.”
Tech Launch Arizona creates ecosystem of invention, commercialization / Arizona Daily Star
University of Arizona’s Tech Launch Arizona, created to commercialize inventions stemming from university research, reports record accomplishments in commercialization for fiscal year 2015. Read also: Fusing chemistry, commerce a success
STEM champion looks to help girls of color / Arizona Republic
The Center for Gender Equity in Science and Technology at Arizona State University has launched to work to improve access, interest, and knowledge in science, technology, engineering and math for girls of color.
Working to help babies who are born too soon / Arizona Daily Star
University of Arizona senior Shivani Misra, a Galileo Circle Scholar and Flinn Scholar, writes about her research and interest in the impact of atypical brain development of kids who are born preterm.
New AZ STEM program seeking to get schools collaborating with each other / Phoenix Business Journal
Arizona SciTech, Intel Corp. and Arizona Science Center are starting a new program to get K-12 schools to work together more in science, technology, engineering and math.
Tucson cancer-drug firm eyes IPO to raise $29 million / Arizona Daily Star
Cancer Prevention Pharmaceuticals Inc., a Tucson-based cancer-drug company, is looking to raise $29 million in an initial public offering of stock while continuing to raise private funding and form key partnerships.
Whether it’s bioscience corridors or trying to be a so-called Silicon Desert, Arizona wants to prove that making a commitment to science and research will be a major boon to the state’s economy.
Researchers hope to develop pancreatic cancer screening / Arizona Republic
The Early Detection Program at the Molecular Medicine Institute, part of the HonorHealth Research Institute, has a study open that offers a personalized approach to cancer-risk assessment for those who feel they may be at risk for developing pancreatic cancer.